Related Experiment Video
Updated: Apr 29, 2026

14:49
Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro
Published on: April 15, 2022
4.6K
Three-dimensional biomaterial degradation - Material choice, design and extrinsic factor considerations
Lara Yildirimer1, Alexander M Seifalian2
1Centre for Nanotechnology & Regenerative Medicine, UCL Division of Surgery & Interventional Science, University College London, UK.
Biotechnology Advances
|May 27, 2014
Summary
Scientists are shifting from top-down to bottom-up biomaterial fabrication for better control over degradation and cell release in regenerative medicine. This review explores controllable bottom-up methods for tissue engineering, focusing on growth factor and stem cell delivery.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Precise control over biomaterial degradation is crucial for regenerative medicine.
- Conventional top-down fabrication methods face limitations in fine-tuning degradation.
- Nature-inspired bottom-up assembly offers a promising alternative for 'designer materials'.
Purpose of the Study:
- To review controllable bottom-up scaffold fabrication methods.
- To investigate how scaffold design and fabrication influence degradation and release kinetics.
- To highlight challenges and solutions for delivering multiple therapeutic agents and overcoming degradation product toxicities.
Main Methods:
- Literature review of scaffold fabrication techniques.
- Analysis of bottom-up assembly approaches.
- Discussion of controlled release strategies for cells, growth factors, and therapeutic agents.
Main Results:
- Bottom-up fabrication offers enhanced control over biomaterial degradation and release profiles.
- Scaffold design significantly impacts degradation rates and the release of incorporated elements.
- Challenges remain in orchestrating the release of multiple agents and managing degradation byproducts.
Conclusions:
- Controllable bottom-up fabrication methods are essential for advancing regenerative medicine.
- Further research is needed to optimize scaffold design for precise degradation and synchronized agent release.
- Addressing degradation product toxicity is critical for clinical translation of engineered tissues.

